CA2010274C - Implants et dispositifs chirurgicaux biodegradables - Google Patents

Implants et dispositifs chirurgicaux biodegradables Download PDF

Info

Publication number: CA2010274C
Authority: CA; Canada
Prior art keywords: implant; set forth; partially; biodegradable; fibres
Prior art date: 1988-11-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA002010274A

Other languages

English (en)

Other versions

CA2010274A1 (fr

Inventor

Martti Talja

Pertti Tormala

Pentti Rokkanen

Seppo Vainionpaa

Timo Pohjonen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Biocon Oy

Original Assignee

Biocon Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-11-10

Filing date

1990-02-16

Publication date

2001-04-03

1988-11-10 Priority claimed from FI885164A external-priority patent/FI85223C/fi

1990-02-16 Application filed by Biocon Oy filed Critical Biocon Oy

1990-02-16 Priority to CA002010274A priority Critical patent/CA2010274C/fr

1991-08-16 Publication of CA2010274A1 publication Critical patent/CA2010274A1/fr

2001-04-03 Application granted granted Critical

2001-04-03 Publication of CA2010274C publication Critical patent/CA2010274C/fr

2010-02-16 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

239000007943 implant Substances 0.000 title claims abstract description 52
239000000463 material Substances 0.000 claims abstract description 26
230000002787 reinforcement Effects 0.000 claims abstract description 24
238000004804 winding Methods 0.000 claims abstract description 24
238000005304 joining Methods 0.000 claims abstract description 4
229920000642 polymer Polymers 0.000 claims description 38
210000001519 tissue Anatomy 0.000 claims description 36
229920001577 copolymer Polymers 0.000 claims description 22
239000011159 matrix material Substances 0.000 claims description 21
238000000034 method Methods 0.000 claims description 20
210000001724 microfibril Anatomy 0.000 claims description 15
229920002988 biodegradable polymer Polymers 0.000 claims description 12
239000004621 biodegradable polymer Substances 0.000 claims description 12
239000000203 mixture Substances 0.000 claims description 9
210000000056 organ Anatomy 0.000 claims description 7
238000004519 manufacturing process Methods 0.000 claims description 6
239000000919 ceramic Substances 0.000 claims description 5
210000004204 blood vessel Anatomy 0.000 claims description 4
230000003872 anastomosis Effects 0.000 claims description 3
238000001816 cooling Methods 0.000 claims description 3
239000004744 fabric Substances 0.000 claims description 3
238000009940 knitting Methods 0.000 claims description 3
238000010276 construction Methods 0.000 claims 1
229920000954 Polyglycolide Polymers 0.000 description 28
239000004633 polyglycolic acid Substances 0.000 description 27
229920001432 poly(L-lactide) Polymers 0.000 description 16
206010061592 cardiac fibrillation Diseases 0.000 description 13
230000002600 fibrillogenic effect Effects 0.000 description 13
241001465754 Metazoa Species 0.000 description 11
210000003708 urethra Anatomy 0.000 description 11
206010052428 Wound Diseases 0.000 description 10
208000027418 Wounds and injury Diseases 0.000 description 10
239000013078 crystal Substances 0.000 description 10
229920000747 poly(lactic acid) Polymers 0.000 description 8
229920001244 Poly(D,L-lactide) Polymers 0.000 description 7
JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 7
238000012360 testing method Methods 0.000 description 7
210000003462 vein Anatomy 0.000 description 7
210000000013 bile duct Anatomy 0.000 description 6
230000003014 reinforcing effect Effects 0.000 description 6
230000000694 effects Effects 0.000 description 5
RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
230000006835 compression Effects 0.000 description 4
238000007906 compression Methods 0.000 description 4
239000000835 fiber Substances 0.000 description 4
230000002496 gastric effect Effects 0.000 description 4
230000035876 healing Effects 0.000 description 4
238000001746 injection moulding Methods 0.000 description 4
210000003734 kidney Anatomy 0.000 description 4
WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 4
229920003023 plastic Polymers 0.000 description 4
239000004033 plastic Substances 0.000 description 4
229920002635 polyurethane Polymers 0.000 description 4
239000004814 polyurethane Substances 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
230000008569 process Effects 0.000 description 4
239000007787 solid Substances 0.000 description 4
210000003932 urinary bladder Anatomy 0.000 description 4
206010002091 Anaesthesia Diseases 0.000 description 3
229920001651 Cyanoacrylate Polymers 0.000 description 3
241000283973 Oryctolagus cuniculus Species 0.000 description 3
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
239000004372 Polyvinyl alcohol Substances 0.000 description 3
238000001949 anaesthesia Methods 0.000 description 3
230000037005 anaesthesia Effects 0.000 description 3
239000002131 composite material Substances 0.000 description 3
230000007547 defect Effects 0.000 description 3
210000000936 intestine Anatomy 0.000 description 3
239000002245 particle Substances 0.000 description 3
239000002861 polymer material Substances 0.000 description 3
229920006324 polyoxymethylene Polymers 0.000 description 3
229920002451 polyvinyl alcohol Polymers 0.000 description 3
239000002994 raw material Substances 0.000 description 3
239000000243 solution Substances 0.000 description 3
238000001356 surgical procedure Methods 0.000 description 3
229920001169 thermoplastic Polymers 0.000 description 3
238000005303 weighing Methods 0.000 description 3
JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 2
229920002101 Chitin Polymers 0.000 description 2
102000008186 Collagen Human genes 0.000 description 2
108010035532 Collagen Proteins 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 2
MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 2
229930182556 Polyacetal Natural products 0.000 description 2
229910000831 Steel Inorganic materials 0.000 description 2
239000004809 Teflon Substances 0.000 description 2
229920006362 Teflon® Polymers 0.000 description 2
210000000683 abdominal cavity Anatomy 0.000 description 2
239000002253 acid Substances 0.000 description 2
230000009471 action Effects 0.000 description 2
230000004075 alteration Effects 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
238000005452 bending Methods 0.000 description 2
239000012867 bioactive agent Substances 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
239000002729 catgut Substances 0.000 description 2
229920001436 collagen Polymers 0.000 description 2
238000000748 compression moulding Methods 0.000 description 2
230000007812 deficiency Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
238000002224 dissection Methods 0.000 description 2
238000001125 extrusion Methods 0.000 description 2
210000003191 femoral vein Anatomy 0.000 description 2
238000003384 imaging method Methods 0.000 description 2
238000002513 implantation Methods 0.000 description 2
238000011068 loading method Methods 0.000 description 2
239000000155 melt Substances 0.000 description 2
238000002844 melting Methods 0.000 description 2
230000008018 melting Effects 0.000 description 2
239000012528 membrane Substances 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
210000005036 nerve Anatomy 0.000 description 2
229960001412 pentobarbital Drugs 0.000 description 2
229920000573 polyethylene Polymers 0.000 description 2
239000000047 product Substances 0.000 description 2
239000000700 radioactive tracer Substances 0.000 description 2
239000010959 steel Substances 0.000 description 2
239000004416 thermosoftening plastic Substances 0.000 description 2
210000000626 ureter Anatomy 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 2
NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
102000018997 Growth Hormone Human genes 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
229920002201 Oxidized cellulose Polymers 0.000 description 1
229920005689 PLLA-PGA Polymers 0.000 description 1
241001474977 Palla Species 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
208000002847 Surgical Wound Diseases 0.000 description 1
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
238000002441 X-ray diffraction Methods 0.000 description 1
230000003187 abdominal effect Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000000654 additive Substances 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
229920006125 amorphous polymer Polymers 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
230000003444 anaesthetic effect Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000003146 anticoagulant agent Substances 0.000 description 1
229940127219 anticoagulant drug Drugs 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
210000000941 bile Anatomy 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
238000010504 bond cleavage reaction Methods 0.000 description 1
238000009954 braiding Methods 0.000 description 1
239000011575 calcium Substances 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
229910010293 ceramic material Inorganic materials 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
239000003433 contraceptive agent Substances 0.000 description 1
229940124558 contraceptive agent Drugs 0.000 description 1
230000007797 corrosion Effects 0.000 description 1
238000005260 corrosion Methods 0.000 description 1
229940127089 cytotoxic agent Drugs 0.000 description 1
230000006378 damage Effects 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
238000010218 electron microscopic analysis Methods 0.000 description 1
229950010048 enbucrilate Drugs 0.000 description 1
JJJFUHOGVZWXNQ-UHFFFAOYSA-N enbucrilate Chemical compound CCCCOC(=O)C(=C)C#N JJJFUHOGVZWXNQ-UHFFFAOYSA-N 0.000 description 1
210000003038 endothelium Anatomy 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
238000000886 hydrostatic extrusion Methods 0.000 description 1
238000005470 impregnation Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000009434 installation Methods 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
210000003141 lower extremity Anatomy 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
238000001000 micrograph Methods 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
230000003387 muscular Effects 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
235000006408 oxalic acid Nutrition 0.000 description 1
229940107304 oxidized cellulose Drugs 0.000 description 1
239000004014 plasticizer Substances 0.000 description 1
230000010287 polarization Effects 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920006149 polyester-amide block copolymer Polymers 0.000 description 1
229920002643 polyglutamic acid Polymers 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
239000000843 powder Substances 0.000 description 1
230000002265 prevention Effects 0.000 description 1
238000007639 printing Methods 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000005855 radiation Effects 0.000 description 1
239000012925 reference material Substances 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
238000005096 rolling process Methods 0.000 description 1
230000007017 scission Effects 0.000 description 1
230000028327 secretion Effects 0.000 description 1
239000011265 semifinished product Substances 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000007493 shaping process Methods 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
238000011282 treatment Methods 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
230000002618 waking effect Effects 0.000 description 1
238000009941 weaving Methods 0.000 description 1
238000009736 wetting Methods 0.000 description 1
239000003357 wound healing promoting agent Substances 0.000 description 1

Landscapes

Materials For Medical Uses (AREA)
Prostheses (AREA)

CA002010274A 1988-11-10 1990-02-16 Implants et dispositifs chirurgicaux biodegradables Expired - Fee Related CA2010274C (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA002010274A CA2010274C (fr)	1988-11-10	1990-02-16	Implants et dispositifs chirurgicaux biodegradables

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FI885164A FI85223C (fi)	1988-11-10	1988-11-10	Biodegraderande kirurgiska implant och medel.
CA002010274A CA2010274C (fr)	1988-11-10	1990-02-16	Implants et dispositifs chirurgicaux biodegradables

Publications (2)

Publication Number	Publication Date
CA2010274A1 CA2010274A1 (fr)	1991-08-16
CA2010274C true CA2010274C (fr)	2001-04-03

Family

ID=25673959

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002010274A Expired - Fee Related CA2010274C (fr)	1988-11-10	1990-02-16	Implants et dispositifs chirurgicaux biodegradables

Country Status (1)

Country	Link
CA (1)	CA2010274C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN111925227B (zh) *	2020-01-19	2022-04-08	湖南碳康生物科技有限公司	一种碳纤维复合材料人工气管支架及其制备方法

1990
- 1990-02-16 CA CA002010274A patent/CA2010274C/fr not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2010274A1 (fr)	1991-08-16

Legal Events

Date	Code	Title	Description
1995-09-12	EEER	Examination request
2003-02-17	MKLA	Lapsed

Publication	Publication Date	Title
AU636311B2 (en)	1993-04-29	Biodegradable surgical implants and devices
US6171338B1 (en)	2001-01-09	Biodegradable surgical implants and devices
CA1311689C (fr)	1992-12-22	Materiaux et instruments chirurgicaux
US6709452B1 (en)	2004-03-23	Biodegradable surgical implants
US6524345B1 (en)	2003-02-25	Surgical implant
FI88111B (fi)	1992-12-31	Sjaelvfoerstaerkande kirurgiska material och medel
JP3779327B2 (ja)	2006-05-24	組織条件下分解性材料及びそれを製造するための方法
EP3019209B1 (fr)	2018-10-31	Ancrages de suture souples
EP0861097B1 (fr)	2005-03-09	Implant biodegradable en materiau a base de polymere et son procede de fabrication
US7582108B2 (en)	2009-09-01	Tubular implant
JP2909116B2 (ja)	1999-06-23	補強型生体機能材料用重合体フィルム
EP2344079A2 (fr)	2011-07-20	Systèmes de fixation de fractures
US20080255561A1 (en)	2008-10-16	Medical device
CA2010274C (fr)	2001-04-03	Implants et dispositifs chirurgicaux biodegradables